These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 718857)

  • 1. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of human [9-leucine-B] Insulin.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4071-76. PubMed ID: 963021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
    Cosmatos A; Okada Y; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of seventeen analogues of human insulin.
    Märki F; de Gasparo M; Eisler K; Kamber B; Riniker B; Rittel W; Sieber P
    Hoppe Seylers Z Physiol Chem; 1979 Nov; 360(11):1619-32. PubMed ID: 511097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-chain shortening of matrix-bound insulin with pepsin, II. Preparation and properties of camel des-pentapeptide (B26-30)- and des-PheB1-des-pentapeptide (B26-30)- insulin.
    Danho WO; Gattner HG; Nissen D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1405-12. PubMed ID: 1100508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a biologically active truncated insulin. Des(pentapeptide B23-30) human (porcine) insulin.
    Katsoyannis PG; Ginos J; Schwartz GP; Cosmatos A
    J Chem Soc Perkin 1; 1974; 11(0):1311-7. PubMed ID: 4859516
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological activity in vitro and in vivo of different insulin derivatives (author's transl)].
    Rager K; Buss U
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):847-51. PubMed ID: 1181277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [21-arginine-A] insulin: a biologically active analog.
    Ferderigos N; Cosmatos A; Ferderigos A; Katsoyannis PG
    Int J Pept Protein Res; 1979 Jan; 13(1):43-53. PubMed ID: 422323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies on des-pentapeptide (B26-30)-insulin. I. The preparation and properties of des-pentapeptide-insulin.
    Sci Sin; 1976; 19(3):351-7. PubMed ID: 788152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of insulin: preparation and biological activity of guinea pig des B-Asp30,des-A-Asn21-insulin.
    Yip CC; Moule ML
    Can J Biochem; 1976 Oct; 54(10):866-71. PubMed ID: 990989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LeuB24]- and [LeuB25]insulins are not antagonists of lipogenesis in adipocytes.
    Diaconescu C; Saunders D; Gattner HG; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1982 Feb; 363(2):187-92. PubMed ID: 7037593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of chemically modified insulins.
    Dron DI; Jones RH; Sönksen PH; Thomas JH; Brandenburg D
    Diabetologia; 1980 Jan; 18(1):59-63. PubMed ID: 6988266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and activity of insulin. XII. Further studies on biologically acitve synthetic fragments of the B-chain.
    Weitzel G; Eisele K; Schulz V; Stock W
    Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):321-30. PubMed ID: 4803476
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological activity of synthetic human insulin.
    Märki F; Albrecht W
    Diabetologia; 1977 Aug; 13(4):293-5. PubMed ID: 913921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.